Skip to Content

Advanced Search

Sign In
|
Create a Profile
|
Quick Order
|
Shopping Cart (0 items)
|
USA

Select another country:

CCRF-CEM [CCRF CEM] (ATCC^® CCL-119^™)

Organism: Homo sapiens, human / Cell Type: T lymphoblast / Tissue: peripheral blood / Disease: acute lymphoblastic leukemia

CCRF-CEM [CCRF CEM] ATCC^® CCL-119^™

frozen

For-Profit: $431.00 Non-Profit: $359.17

Qty:

Recommended for this product

Add ALL recommended products to cart

Permits and Restrictions	View Permits
Organism	Homo sapiens, human
Tissue	peripheral blood
Cell Type	T lymphoblast
Product Format	frozen
Morphology	lymphoblast
Culture Properties	suspension
Biosafety Level	1
Disease	acute lymphoblastic leukemia
Age	4 years juvenile
Gender	female
Ethnicity	Caucasian
Applications	This cell line is a suitable transfection host.
Storage Conditions	liquid nitrogen vapor phase

Karyotype	modal number = 47; range = 41 to 95. Fifty karyotypes showed no consistent loss or gain of particular chromosomes. Twenty-eight percent of the cells with 45 chromosomes were C-; 53% of all cells had an extra D and 35% had an extra F. Only N1 and N18 were not affected by gain or loss. No marker chromosomes noted.
Images
Derivation	Human lymphoblasts from peripheral blood of a child with acute leukemia.
Clinical Data	Caucasian female 4 years juvenile
Antigen Expression	CD3; Homo sapiens, expressed CD4; Homo sapiens, expressed CD5; Homo sapiens, expressed CD7; Homo sapiens, expressed
Genes Expressed	CD3; Homo sapiens, expressed ,CD5; Homo sapiens, expressed ,CD7; Homo sapiens, expressed ,CD4; Homo sapiens, expressed
Tumorigenic	Yes
Effects	Yes, in syrian hamsters RefAdams RA, et al. Leukemia: serial transplantation of human leukemic lymphoblasts in the newborn Syrian hamster. Cancer Res. 27: 772-783, 1967. PubMed: 4295047

Complete Growth Medium	The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing	Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 to 3 X 10⁵ viable cells/mL. Maintain cell density between 2 to 3 X 10⁵ and 1 to 2 X 10⁶ viable cells/mL. Medium Renewal: Add fresh medium (20% to 30% by volume) every 2 to 3 days
Cryopreservation	Freeze medium: Complete growth medium supplemented with 7.5% DMSO. Storage temperature: liquid nitrogen vapor phase
Culture Conditions	Temperature: 37°C

STR Profile	Amelogenin: X CSF1PO: 10,11 D13S317: 11,12 D16S539: 10,13 D5S818: 12,13 D7S820: 9,13 THO1: 6,7 TPOX: 8 vWA: 17,19
Isoenzymes	ADA, 1 ES-D, 1 G6PD, B GLO-I, 1 PEP-D, 1 PGD, C PGM1, 1 PGM3, 0

Name of Depositor	GE Foley
Year of Origin	November, 1964
References	Foley GE, et al. Continous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522-529, 1965. PubMed: 14278051 Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. USA 90: 4708-4712, 1993. PubMed: 8506323 Adams RA. Formal discussion: the role of transplantation in the experimental investigation of human leukemia and lymphoma. Cancer Res. 27: 2479-2482, 1967. PubMed: 4170381 Uzman BG, et al. Morphologic variations in human leukemic lymphoblasts (CCRF-CEM cells) after long-term culture and exposure to chemotherapeutic agents. A study with the electron microscope. Cancer 19: 1725-1742, 1966. PubMed: 5224274 Adams RA, et al. Leukemia: serial transplantation of human leukemic lymphoblasts in the newborn Syrian hamster. Cancer Res. 27: 772-783, 1967. PubMed: 4295047 Miranda L, et al. Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 93: 7695-7700, 1996. PubMed: 8755538 CCRF-CEM is a T lymphoblastoid cell line derived by G.E. Foley, et al. using cells obtained in November, 1964 from peripheral blood buffy coat of a 4-year-old Caucasian female with acute lymphoblastic leukemia.
Cross References	Nucleotide (GenBank) : Z23090 H.sapiens mRNA for 28 kDa heat shock protein. Nucleotide (GenBank) : AF146431 Homo sapiens cell-line CCRF-CEM sodium/hydrogen exchanger isoform 1 mRNA, complete cds. Nucleotide (GenBank) : Z12846 HSA08C081 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 08C08, mRNA sequence. Nucleotide (GenBank) : Z13104 HSA25H071 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 25H07, mRNA sequence. Nucleotide (GenBank) : Z13398 HSA45A081 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 45A08, mRNA sequence. Nucleotide (GenBank) : Z13431 HSA48B021 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 48B02, mRNA sequence. Nucleotide (GenBank) : Z13562 HSA57F051 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 57F05, mRNA sequence. Nucleotide (GenBank) : Z13677 HSA65D041 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 65D04, mRNA sequence. Nucleotide (GenBank) : Z13711 HSA68F071 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 68F07, mRNA sequence. Nucleotide (GenBank) : Z13717 HSA69C041 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 69C04, mRNA sequence. Nucleotide (GenBank) : Z15500 HSA23D012 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 23D01, mRNA sequence. Nucleotide (GenBank) : Z15555 HSA27A032 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 27A03, mRNA sequence. Nucleotide (GenBank) : Z16011 HSA56G072 CLONTECH cDNA library CCRF-CEM, cat# HL1063g Homo sapiens cDNA clone 56G07, mRNA sequence.

Permits	These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation	Product Sheet Certificate of Analysis MSDS
Other Documentation	Cell Micrograph Cell Micrograph Leukemia cell line mutation data
References	Foley GE, et al. Continous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522-529, 1965. PubMed: 14278051 Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. USA 90: 4708-4712, 1993. PubMed: 8506323 Adams RA. Formal discussion: the role of transplantation in the experimental investigation of human leukemia and lymphoma. Cancer Res. 27: 2479-2482, 1967. PubMed: 4170381 Uzman BG, et al. Morphologic variations in human leukemic lymphoblasts (CCRF-CEM cells) after long-term culture and exposure to chemotherapeutic agents. A study with the electron microscope. Cancer 19: 1725-1742, 1966. PubMed: 5224274 Adams RA, et al. Leukemia: serial transplantation of human leukemic lymphoblasts in the newborn Syrian hamster. Cancer Res. 27: 772-783, 1967. PubMed: 4295047 Miranda L, et al. Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 93: 7695-7700, 1996. PubMed: 8755538 CCRF-CEM is a T lymphoblastoid cell line derived by G.E. Foley, et al. using cells obtained in November, 1964 from peripheral blood buffy coat of a 4-year-old Caucasian female with acute lymphoblastic leukemia.

Related Products

CEM/C2 (ATCC^® CRL-2264^™)

frozen

For-Profit: $551.00 Non-Profit: $459.17

CEM/C1 (ATCC^® CRL-2265^™)

frozen

For-Profit: $551.00 Non-Profit: $459.17

8E5 [derivative of CEM] (ATCC^® CRL-8993^™)

frozen

For-Profit: $551.00 Non-Profit: $459.17

CEM-CM3 (ATCC^® TIB-195^™)

frozen

For-Profit: $551.00 Non-Profit: $459.17

Leukemia Cell Line Panel (ATCC^® TCP-1010^™)

frozen

For-Profit: $2,400.00 Non-Profit: $2,000.00